FREE Account Opening + No Clearing Fees
Loading...

Krsnaa Diagnostics IPO vs Nuvoco IPO

Comparision between Krsnaa Diagnostics IPO and Nuvoco IPO.

IPO Details

Krsnaa Diagnostics IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Nuvoco IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Krsnaa Diagnostics IPO is up to ₹1,213.33 Cr whereas the issue size of the Nuvoco IPO is up to ₹5,000.00 Cr. The final issue price of Krsnaa Diagnostics IPO is ₹954.00 per share and of Nuvoco IPO is ₹570.00 per share.

  Krsnaa Diagnostics IPO Nuvoco IPO
Face Value ₹5 per share ₹10 per share
Issue Price (Lower) ₹933.00 per share ₹560.00 per share
Issue Price (Upper) ₹954.00 per share ₹570.00 per share
Issue Price (Final) ₹954.00 per share ₹570.00 per share
Discount (Retail)
Discount (Employee) ₹93.00 per share
Market Lot Size 15 shares 26 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹400.00 Cr up to ₹1,500.00 Cr
OFS Issue Size 85,25,520 shares
OFS Issue Size (Amount) up to ₹813.33 Cr up to ₹3,500.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,213.33 Cr up to ₹5,000.00 Cr

IPO Timetable

Krsnaa Diagnostics IPO opens on Aug 04, 2021, while Nuvoco IPO opens on Aug 09, 2021. The closing date of Krsnaa Diagnostics IPO and Nuvoco IPO is Aug 06, 2021, and Aug 11, 2021, respectively.

  Krsnaa Diagnostics IPO Nuvoco IPO
Anchor Bid Date
Issue Open Aug 04, 2021 Aug 09, 2021
Issue Close Aug 06, 2021 Aug 11, 2021
Basis Of Allotment (Tentative) Aug 11, 2021 Aug 17, 2021
Initiation of Refunds (Tentative) Aug 12, 2021 Aug 18, 2021
Credit of Share (Tentative) Aug 13, 2021 Aug 20, 2021
Listing date (Tentative) Aug 16, 2021 Aug 23, 2021
Anchor Lockin End date 1 Sep 10, 2021 Sep 16, 2021
Anchor Lockin End date 2 Nov 09, 2021 Nov 15, 2021

Financials

Krsnaa Diagnostics IPO P/E ratio is , as compared to Nuvoco IPO P/E ratio of .

  Krsnaa Diagnostics IPO Nuvoco IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 6,045.30 6,299.82 5,289.85
Total Revenue 6,614.76 2,713.79 2,143.15
Profit After Tax 1,849.29 (1,119.51) (580.57)
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 1,99,075.70 134,443.22 132,617.03
Total Revenue 75,226.93 68,299.44 71,058.88
Profit After Tax (259.19) 2,492.55 (264.88)
Promoter Shareholding (Pre-Issue) 31.62% 95.24%
Promoter Shareholding (Post-Issue) 27.38% 71.03%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Krsnaa Diagnostics IPO retail investors (RII) are offered 12,50,874 shares while in Nuvoco IPO retail investors are offered 12,50,874 shares. Qualified institutional buyers (QIB) are offered 37,52,625 shares in Krsnaa Diagnostics IPO and 1,78,57,143 shares in Nuvoco IPO.

  Krsnaa Diagnostics IPO Nuvoco IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 37,52,625 shares 1,78,57,143 shares
NII 18,76,312 shares 1,33,92,858 shares
RII 12,50,874 shares 3,12,50,000 shares
Employee 2,32,288 shares 0 shares
Others
Total 71,12,099 shares 6,25,00,001 shares

Bids Received (Subscription)

Krsnaa Diagnostics IPO subscribed 64.38x in total, whereas Nuvoco IPO subscribed 1.71x.

  Krsnaa Diagnostics IPO Nuvoco IPO
QIB (times) 49.83x 4.23x
NII (times) 116.30x 0.66x
Big NII (times)
Small NII (times)
RII (times) 41.95x 0.73x
Employee (times) 0.98x
Other (times)
Total (times) 64.38x 1.71x

Comments

Add a public comment...